- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05722106
Improving Adherence to COVID-19 Prevention Behaviours: Test of Persuasive Messages
The goal of this randomized online experiment was to test the effectiveness of using various persuasive appeals (deontological moral frame, empathy, identifiable victim, goal proximity, and reciprocity) at improving intentions to adhere to prevention behaviors.
Participants indicated their intentions to follow public health guidelines, saw one of six flyers featuring a persuasive appeal or no appeal, then rated their intentions a second time. Known correlates of attitudes toward public health measures were also measured.
Study Overview
Detailed Description
Adherence to non-pharmaceutical interventions (NPIs) for COVID-19, including physical distancing, masking, staying home while sick, and avoiding crowded indoor spaces remain critical for limiting the spread of COVID-19.
This study tests the effectiveness of using various persuasive appeals (deontological moral frame, empathy, identifiable victim, goal proximity, and reciprocity) at improving intentions to adhere to prevention behaviors.
A randomized online experiment using a representative sample of adult Canadian residents with respect to age, ethnicity, and province of residence was conducted between March 3-6, 2021. Participants indicated their intentions to follow public health guidelines, saw one of six flyers featuring a persuasive appeal or no appeal, then rated their intentions a second time. Known correlates of attitudes toward public health measures were also measured.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T2N1N4
- Lucid Marketplace
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult Canadian residents
- Target quotas for province of residence, age, gender, and ethnicity were set to obtain a demographically representative sample based on the 2016 census data
Exclusion Criteria:
- Province of residence, age, gender, and ethnicity once quotas are filled
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Control - Info only
Participants read a flyer containing the following message: The virus spreads mainly between people who are in close contact with one another. You can help prevent the spread of COVID-19. We can all do our part:
|
Persuasive appeals were manipulated using promotional flyers ostensibly distributed by the Public Health Agency of Canada.
|
|
EXPERIMENTAL: Deontological
Participants read a flyer containing the following message: The virus spreads mainly between people who are in close contact with one another. You can help prevent the spread of COVID-19. We can all do our part:
|
Persuasive appeals were manipulated using promotional flyers ostensibly distributed by the Public Health Agency of Canada.
|
|
EXPERIMENTAL: Empathy
Participants read a flyer containing the following message: The sick, elderly, and immunocompromised need our help. We all have a choice. If we don't take the right actions, we risk the lives of others. But we can protect those most likely to be harmed. We can protect those who are vulnerable by taking simple steps:
|
Persuasive appeals were manipulated using promotional flyers ostensibly distributed by the Public Health Agency of Canada.
|
|
EXPERIMENTAL: Identifiable victim
Participants read a flyer containing the following message: A few weeks ago, Sam was a healthy 26-year-old with no medical complications. The he suddenly came down with a bad cough and a feeling like he could not breath. He tested positive for COVID-19, and is now hospitalized, receiving oxygen from a ventilator, and fighting for his life. This could be any of us. Reduce the risk to yourself and other:
|
Persuasive appeals were manipulated using promotional flyers ostensibly distributed by the Public Health Agency of Canada.
|
|
EXPERIMENTAL: Goal proximity
Participants read a flyer containing the following message: The recent development of safe and effective vaccines gives us great hope. We see the light at the end of the tunnel, but we are not quite there yet. Until a large proportion of the population is immunized, we must remain vigilant and double our efforts to prevent the spread of COVID-19.
|
Persuasive appeals were manipulated using promotional flyers ostensibly distributed by the Public Health Agency of Canada.
|
|
EXPERIMENTAL: Reciprocity
Participants read a flyer containing the following message: Doctors, nurses, and other healthcare workers are working around the clock, often risking their lives to care for patients with the coronavirus. Working long hours in highly infectious environments, many of them are falling ill. As our healthcare workers put their lives on the line, we can do our part:
|
Persuasive appeals were manipulated using promotional flyers ostensibly distributed by the Public Health Agency of Canada.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in intentions to engage in prevention behaviours
Time Frame: Same day
|
Index variables for intentions to engage in prevention behaviors (pre- and post-treatment) were created by averaging across six items (1.
Limit my physical contact with others when possible, 2. Completely avoid any unnecessary physical contact with others [e.g., hugging or handshakes], 3. Avoid crowded indoor spaces, 4. Wear a mask when I leave the house, 5. Wash my hands as much as possible, and 6.
Stay home when mildly sick) measured on 100-point sliding scales (0 = Strongly disagree, 50 = Neither agree nor disagree, 100 = Strongly agree).
|
Same day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mehdi Mourali, PhD, University of Calgary
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- REB21-0173
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19
-
PfizerActive, not recruitingCOVID-19 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | COVID-19 Vaccines | SARS-CoV-2 Infection, COVID19 | COVID-19 Vaccination | SARS-CoV-2 Infection, COVID-19 | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionUnited States
-
Shanghai Public Health Clinical CenterNot yet recruiting
-
Duke UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Eggensberger OHGBavarian Health and Food Safety Authority (LGL)RecruitingPost COVID-19 Condition | Post COVID-19 | Post COVID-19 Syndrome | Long COVID-19 Syndrome | Post COVID-19 Condition (PCC)Germany
-
PfizerRecruitingRespiratory Tract Diseases | COVID-19 | Pneumonia | Lung Diseases | Coronavirus Disease 2019 | Coronavirus Disease 2019 (COVID-19) | COVID-19 Infection | Upper Respiratory Tract Infections | Respiratory Tract Infection | COVID-19 (Coronavirus Disease 2019) | COVID-19 SARS-CoV-2 InfectionBelgium
-
ModeX Therapeutics, An OPKO Health CompanyRecruitingCOVID -19 | COVID-19 (Prevention)United States
-
Lawson Research Institute of St. Joseph'sCanadian Institutes of Health Research (CIHR); Western University, CanadaRecruitingFatigue | Post-COVID-19 Syndrome | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19 | Long-COVID | Post-COVID ConditionCanada
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Yang I. PachankisActive, not recruitingCOVID-19 Respiratory Infection | COVID-19 Stress Syndrome | COVID-19 Vaccine Adverse Reaction | COVID-19-Associated Thromboembolism | COVID-19 Post-Intensive Care Syndrome | COVID-19-Associated StrokeChina
-
University of Missouri, Kansas CityNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruitingCOVID-19 Testing BehaviorsUnited States
Clinical Trials on Persuasive Appeal
-
State University of New York - Downstate Medical...National Institute of Nursing Research (NINR)Completed
-
Rutgers, The State University of New JerseyCompleted
-
Penn State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)TerminatedFeeding BehaviorUnited States
-
University of MiamiTerminatedCervical CancerUnited States
-
University of Milano BicoccaCompleted
-
Rhode Island HospitalCompletedHepatitis C | HivUnited States
-
Monash University MalaysiaMonash UniversityCompletedHypertension | Behavior and Behavior MechanismsMalaysia
-
University of OuluCompleted
-
Qazvin University Of Medical SciencesCompletedHealth BehaviorIran, Islamic Republic of
-
University of DundeeUniversity of Southampton; Newcastle University; University of Aberdeen; Chief... and other collaboratorsCompletedAntibiotic Prescribing by GPs for URTIUnited Kingdom